dolasetron has been researched along with granisetron in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 23 (69.70) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, A; De Ponti, F; Poluzzi, E; Recanatini, M | 1 |
| Li, J; Rajamani, R; Reynolds, CH; Tounge, BA | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Caron, G; Ermondi, G; Visentin, S | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gandara, DR; Hesketh, PJ | 1 |
| Alon, E; Biro, P | 1 |
| Kobayashi, S; Kumai, T; Nakura, H; Tanaka, M; Tateishi, T; Watanabe, M | 1 |
| Aranda, E; Auclerc, G; Audhuy, B; Benhammouda, A; Bleiberg, H; Cals, L; Cappelaere, P; Cattan, A; Cervantes, A; Chevallier, B; Claverie, N; Conroy, T; Cupissol, D; De Grève, J; Diaz-Rubio, E; Fabbro, M; Faraldi, M; Khayat, D; Martin, M; Rivière, A; Seitz, JF | 1 |
| Fisher, DM | 1 |
| Benedict, CR; Brown, AM; Kuryshev, YA; Rampe, D; Wang, L | 1 |
| Keefe, DL | 1 |
| Markman, M | 1 |
| Steiner, MA; Theisen, J; Vermeulen, LC; Yorgason, RZ | 1 |
| Koeller, JM; Navari, RM | 1 |
| Tan, M | 1 |
| Seth, R; Tan, M; Xu, R | 1 |
| Olver, IN | 1 |
| Cartwright, J; Frangoul, H; Ho, RH; Jones, E; Koyama, T; Kuttesch, J; Shankar, S; Whitlock, JA | 1 |
| Board, R; Board, T | 1 |
| Janicki, PK; Jarzembowski, TM; Rossi, M; Schuler, HG | 1 |
| Awab, A; Chaudhary, L; Hamadani, M; Tfayli, A | 1 |
| Arnold, D; Grothey, A; Hinke, A; Jordan, K; Schmoll, HJ; Voigt, W; Wolf, HH | 1 |
| Ahlburg, P; Nielsen, JO | 1 |
| Wilkes, G | 1 |
| Awan, FT; Chaudhary, L; Hamadani, M; Khan, JK; Kojouri, K; Ozer, H; Tfayli, A | 1 |
| Adams, LM; Johnson, B; Kirby, LC; Lebowitz, P; Stoltz, R; Yue, L; Zhang, K | 1 |
| Janicki, PK; Quraishi, SA; Schuler, GH | 1 |
| Ballinari, G; Barbour, SY; Cox, D; Morrow, GR; Schwartzberg, L; Thorn, MD | 1 |
10 review(s) available for dolasetron and granisetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
Topics: Antiemetics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Humans; Indoles; Infusions, Intravenous; Nausea; Ondansetron; Postoperative Complications; Quinolizines; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Electrocardiography; Granisetron; Heart Failure; Humans; Indoles; Middle Aged; Nausea; Neoplasms; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2002 |
Progress in preventing chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Granisetron; Humans; Indoles; Nausea; Neurotransmitter Agents; Ondansetron; Quinolizines; Vomiting | 2002 |
Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.
Topics: Antiemetics; Cardiovascular System; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography; Granisetron; Humans; Indoles; Ondansetron; Quinolizines; Serotonin Antagonists; Surgical Procedures, Operative | 2003 |
Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Humans; Indoles; Nausea; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2003 |
Update on anti-emetics for chemotherapy-induced emesis.
Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Australia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Neoplasms; Ondansetron; Palonosetron; Patient Satisfaction; Prognosis; Quality of Life; Quinolizines; Quinuclidines; Treatment Outcome; Tropisetron; Vomiting | 2005 |
The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
Topics: Adult; Algorithms; Antiemetics; Child; Dexamethasone; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Granisetron; Humans; Indoles; Isoquinolines; Nurse's Role; Nursing Assessment; Ondansetron; Operating Room Nursing; Palonosetron; Patient Selection; Postoperative Nausea and Vomiting; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Risk Assessment; Risk Factors; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists | 2006 |
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indoles; Ondansetron; Quinolizines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2007 |
[Prevention of postoperative nausea and vomiting].
Topics: Antiemetics; Dexamethasone; Droperidol; Evidence-Based Medicine; Granisetron; Humans; Indoles; Metoclopramide; Postoperative Nausea and Vomiting; Quinolizines; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
5 trial(s) available for dolasetron and granisetron
| Article | Year |
|---|---|
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Quinolizines; Serotonin Antagonists; Vomiting | 1996 |
Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study.
Topics: Antiemetics; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Quinolizines; United States; Vomiting | 2004 |
Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype.
Topics: Adult; Cytochrome P-450 CYP2D6; Double-Blind Method; Female; Genotype; Granisetron; Humans; Indoles; Male; Middle Aged; Postoperative Nausea and Vomiting; Prospective Studies; Quinolizines | 2006 |
Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.
Topics: Adolescent; Adult; Antiemetics; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Piperazines; Piperidines; Quinolizines; Vomiting; Young Adult | 2009 |
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting | 2014 |
18 other study(ies) available for dolasetron and granisetron
| Article | Year |
|---|---|
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cluster Analysis; Databases, Factual; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Models, Molecular; Molecular Conformation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2002 |
A two-state homology model of the hERG K+ channel: application to ligand binding.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Ligands; Models, Biological; Models, Molecular; Potassium Channels, Voltage-Gated; Protein Binding; Protein Conformation | 2005 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
GRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: the case of hERG K+ channel blockers.
Topics: Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Potassium Channel Blockers; Quantitative Structure-Activity Relationship | 2009 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Serotonin antagonists: a new class of antiemetic agents.
Topics: Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Metoclopramide; Ondansetron; Quinolizines; Receptors, Serotonin; Serotonin Antagonists; Tropanes; Tropisetron; Vomiting | 1991 |
The activity of dihydropyrimidine dehydrogenase from rat liver was not affected by any of five 5-hydroxytryptamine antagonists.
Topics: Animals; Antiemetics; Antimetabolites, Antineoplastic; Biotransformation; Bridged Bicyclo Compounds, Heterocyclic; Cytosol; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Granisetron; Indoles; Liver; Male; Ondansetron; Oxazines; Oxidoreductases; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tropisetron | 1996 |
Surrogate outcomes: meaningful not!
Topics: Anesthesia; Antiemetics; Granisetron; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 1999 |
Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
Topics: Antiemetics; Cation Transport Proteins; Cell Line; Cloning, Molecular; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electric Stimulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Granisetron; Heart; Humans; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Ondansetron; Potassium Channels; Potassium Channels, Voltage-Gated; Quinolizines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Sodium Channels; Trans-Activators; Transcriptional Regulator ERG; Transfection | 2000 |
Patient outcomes after therapeutic interchange of dolasetron for granisetron.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cohort Studies; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Quinolizines; Therapeutic Equivalency; Treatment Outcome; United States; Vomiting | 2003 |
5HT3-receptor antagonists as antiemetics in cancer.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Neoplasms; Ondansetron; Palonosetron; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tropisetron; Vomiting | 2005 |
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Confusion; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Female; Granisetron; Humans; Indoles; Infusion Pumps; Infusions, Intravenous; Length of Stay; Lorazepam; Male; Mood Disorders; Ondansetron; Patient Acceptance of Health Care; Quinolizines; Retrospective Studies; Self Administration; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
Topics: Antiemetics; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Ondansetron; Organoplatinum Compounds; Palonosetron; Quinolizines; Quinuclidines; Treatment Outcome; Vomiting | 2006 |
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities.
Topics: Adaptor Proteins, Signal Transducing; Adult; Alleles; Databases, Genetic; Electrocardiography; Female; Genotype; Granisetron; Hospitals, University; Humans; Indoles; Long QT Syndrome; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists | 2011 |